OnKure Therapeutics, Inc.
OKUR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001637715
In the last 90 days, OnKure Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 75 institutions reported holding it in 13F filings for Q2 2026, worth $159.0M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in OnKure Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +2 vs. Q4 2021
- Shares held
- 17.3M
- −120.3K (−0.7%) vs. Q4 2021
- Total value
- $50.8M
- −$98.1M (−65.9%) vs. Q4 2021
- New holders
- 5
- 8 more added
- Sold out
- 3
- 13 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OKUR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 75 | $159.0M |
| Q1 2026 | 51 | $113.9M |
| Q4 2025 | 44 | $32.0M |
| Q3 2025 | 42 | $28.1M |
| Q2 2025 | 49 | $25.8M |
| Q1 2025 | 47 | $50.1M |
| Q4 2024 | 51 | $99.2M |
| Q3 2024 | 51 | $49.0M |
| Q2 2024 | 66 | $41.3M |
| Q1 2024 | 62 | $45.4M |
| Q4 2023 | 68 | $40.4M |
| Q3 2023 | 58 | $208.3M |
| Q2 2023 | 52 | $168.9M |
| Q1 2023 | 35 | $102.0M |
| Q4 2022 | 32 | $38.4M |
| Q3 2022 | 33 | $55.1M |
| Q2 2022 | 33 | $43.3M |
| Q1 2022 | 41 | $50.8M |
| Q4 2021 | 39 | $148.9M |
| Q3 2021 | 38 | $136.7M |
| Q2 2021 | 38 | $170.6M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding OnKure Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 4,786,921 | $14.1M | 0.45% | 00.0% | Unchanged |
| Novo Holdings A/S | 3,430,377 | $10.1M | 0.53% | 00.0% | Unchanged |
| RiverVest Venture Management LLC | 2,409,220 | $7.08M | 7.27% | 00.0% | Unchanged |
| Abingworth LLP | 2,073,957 | $6.08M | 1.72% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 1,143,185 | $3.36M | 0.08% | 00.0% | Unchanged |
| Aisling Capital Management LP | 886,075 | $2.60M | 1.41% | 00.0% | Unchanged |
| Tybourne Capital Management (HK) Ltd | 700,000 | $2.06M | 0.12% | −50,000−6.7% | Reduced |
| Franklin Resources Inc | 408,506 | $1.20M | 0.00% | −41,494−9.2% | Reduced |
| Vanguard Group Inc | 360,881 | $1.06M | 0.00% | −6,715−1.8% | Reduced |
| BlackRock Inc. | 317,027 | $932.0K | 0.00% | +1520.0% | Added |
| Ikarian Capital, LLC | 185,597 | $546.0K | 0.17% | +10,597+6.1% | Added |
| Geode Capital Management, LLC | 121,156 | $356.0K | 0.00% | +1,915+1.6% | Added |
| Bridgeway Capital Management, LLC | 100,000 | $294.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 89,253 | $262.0K | 0.00% | +1,190+1.4% | Added |
| Northern Trust Corp | 68,424 | $201.0K | 0.00% | +4,877+7.7% | Added |
| Bank of America Corp | 40,878 | $121.0K | 0.00% | +7,914+24.0% | Added |
| Commonwealth Equity Services, LLC | 22,347 | $65.0K | 0.00% | +22,347 | New |
| Jefferies Group LLC | 21,328 | $62.7K | 0.00% | +21,328 | New |
| Charles Schwab Investment Management Inc | 18,830 | $56.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 17,648 | $52.0K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 17,000 | $50.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 13,438 | $39.0K | 0.00% | −120−0.9% | Reduced |
| Tower Research Capital LLC (TRC) | 9,800 | $29.0K | 0.00% | +8,561+691.0% | Added |
| FMR LLC | 6,289 | $18.0K | 0.00% | −30,411−82.9% | Reduced |
| Wells Fargo & Company | 5,364 | $16.0K | 0.00% | −2,615−32.8% | Reduced |
| Morgan Stanley | 5,409 | $16.0K | 0.00% | −1,739−24.3% | Reduced |
| Deutsche Bank AG | 4,722 | $14.0K | 0.00% | −560−10.6% | Reduced |
| American International Group, Inc. | 4,316 | $13.0K | 0.00% | −303−6.6% | Reduced |
| New York State Common Retirement Fund | 4,210 | $12.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 4,077 | $12.0K | 0.00% | +1,635+67.0% | Added |
| California State Teachers Retirement System | 3,719 | $11.0K | 0.00% | −1,167−23.9% | Reduced |
| Barclays PLC | 3,562 | $10.0K | 0.00% | +3,562 | New |
| Allspring Global Investments Holdings, LLC | 2,271 | $6.00K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 1,500 | $4.00K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,319 | $4.00K | 0.00% | +1,319 | New |
| Amalgamated Financial Corp. | 1,319 | $4.00K | 0.00% | +1,319 | New |
| UBS Group AG | 1,067 | $3.00K | 0.00% | −1,595−59.9% | Reduced |
| Citigroup Inc | 760 | $2.00K | 0.00% | −1,869−71.1% | Reduced |
| Royal Bank of Canada | 533 | $2.00K | 0.00% | −1,582−74.8% | Reduced |
| Legal & General Group Plc | 700 | $2.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 494 | $1.00K | 0.00% | 00.0% | Unchanged |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −28,357−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −24,990−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −13,482−100.0% | Sold out |